In mice, it has been shown that the treatment with recombinant THBS1 may suppress insulin signaling in the cultured muscle cell, which could represent crosstalk between the WAT and skeletal muscle in obesity [113]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.